26èmes Journées franco-belges de Pharmacochimie

JFB 2012

 Orléans, France    24-25 mai 2012

Programme


08:30

Accueil des participants

09:00

Séance inaugurale

Session Chair:

Dr. Franck SUZENET
UNIVERSITÉ D'ORLÉANS, Orléans, France
09:30

L01 - Novel 5-HT7 antagonists for the treatment of migraine

Dr Ali ATES
UCB, Braine-l'Alleud, Belgium
10:20

OC01 - Synthese de molecules d'intérêt pharmaceutique. Contribution à la synthèse des bastadines

Ing Christelle DECAMPS
UMONS, Mons, Belgium
10:40

Pause café et communications par affiches, session 1

Session Chair:

Prof. Bernard PIROTTE
ULG, Liège, Belgium
11:30

L02 - Foldamers: Expanding the Chemical Space

Dr Ivan HUC
IECB & CNRS - UNIVERSITÉ DE BORDEAUX, Bordeaux, France
12:20

OC02 - Design, synthesis and biological evaluation of pyrazole-based kinase inhibitors

Dr Patricia BUSCA
UNIVERSITY PARIS DESCARTES, Paris, France
12:40

OC03 - Design, synthesis and pharmacological evaluation of EGFR/VEGFR tyrosine kinase dual inhibitors

Ms Séverine RAVEZ
ICPAL UNIVERSITÉ LILLE 2, Lille, France
13:00

Déjeuner

Session Chair:

Prof. Francois DUFRASNE
ULB, Bruxelles, Belgium
14:30

OC04 - Synthesis of new molecular tools for the orphan receptor GLIC, homologous protein of the nicotinic acetylcholine receptors

Dr Sandrine DELARUE-COCHIN
UNIVERSITE PARIS SUD, CHATENAY-MALABRY, France
14:50

OC05 - New alpha-galactosylceramides with potent immunoregulatory activity : synthesis and biological evaluation

Dr Muriel PIPELIER
UNIVERSITY OF NANTES, Nantes, France
15:10

OC06 - Study of N1-alkylation of indoles from the reaction of 2(or 3)-aminoindole-3-(or 2)carbonitriles with DMF-dialkylacetals

Prof. Thierry BESSON
UNIVERSITY OF ROUEN, COBRA-IRCOF, Rouen, France
15:30

Pause café et communications par affiches, session 2

Session Chair:

Prof. Sylvain RAULT
UNIVERSITÉ DE CAEN, Caen Cedex, France
16:20

L03 - Promoting Immune Rejection of Tumors by Blocking Tryptophan Catabolism by IDO and TDO

Prof. Benoît VAN DEN EYNDE
LUDWIG INSTITUTE FOR CANCER RESEARCH LTD, UCL, DE DUVE INSTITUTE, Bruxelles, Belgium
17:20

Remise du prix des Journées Franco-belges de pharmacochimie

17:30

Communication orale du lauréat

17:50

Clôture de la séance

19:30

Banquet

Session Chair:

Prof. Bernard MASEREEL
UNAMUR, Namur, Belgium
09:00

L04 - Development of cyclin dependent kinase inhibitors. Investigation of their molecular mechanism of action

Prof. Hervé GALONS
SCT & PARIS DESCARTES UNIVERSITY, Paris, France
09:50

OC07 - Conception, synthese et evaluation de composes ciblant les ADN methyltransferases

Mr Irving BOITTIAUX
FUNDP-UCL, Woluwe Saint Lambert, Belgium
10:10

OC08 - Activite antibacterienne, antioxyante et toxicite aiguë de quelques flavonoïdes

Dr Souâd AKROUM
UNIVERSITY OF JIJEL, Jijel, Algerie
10:30

Pause café et communication par affiche, session 3

Session Chair:

Prof. Raphaël FREDERICK
FUNDP, Brussels-Woluwe, Belgium
11:00

L05 - 3D pharmacophores in computational drug design: tools for hit discovery and lead optimization

Prof. Gerhard WOLBER
FREIE UNIVERSITÄT BERLIN, Berlin, Germany
11:50

OC09 - Identification by a SOSA library screening and structure-activity relationships of succinic acid receptor (SUCNR1 or GPR91) agonist

Mrs Julie GILISSEN
ULG, Liege, Belgium
12:10

OC10 - From the conception of FAAH inhibitors to the discovery of a novel class of selective CB2 cannabinoid receptor agonists in the treatment of experimental colitis

Ing Aurelien TOURTEAU
UNIVERSITE DE LILLE 2, Lille, France
12:30

OC11 - Rational design of myeloperoxidase inhibitors using structure-based virtual screening

Mr Iyas ALDIB
ULB, Brussels , Belgium
12:50

Déjeuner

Session Chair:

Prof. Patrick DEPREUX
UNIVERSITÉ LILLE 2, Lille, France
14:30

OC12 - In vitro characterisation of anticancer properties relating to ferrocenyl and ferrocenophane complexes

Dr Céline BRUYÈRE
ECOLE NATIONALE SUPÉRIEURE DE CHIMIE PARIS, Paris, France
14:50

OC13 - Assessing the free brain/free plasma ratio in vitro in early drug discovery

Mr Maxime CULOT
BBB LAB (LBHE) - UNIVERSITY OF ARTOIS, Lens, France
15:10

L06 - Métabolomique et Chimie Médicinale, vers la découverte de nouvelles cibles thérapeutiques potentielles : application à la Dégénérescence Maculaire Liée à l’Age (DMLA)

Dr Pascal DE TULLIO
ULG, Liege, Belgium
16:00

Remise des prix des meilleures communications par affiche

16:25

Clôture du congrès